Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Blumenthal

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Journal of Neuro-Oncology|June 15, 2020
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practiceWenyin Shi, Deborah T Blumenthal, Nancy Ann Oberheim Bush, et al.
Journal of Neuro-Oncology|January 5, 2021
Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practiceWenyin Shi, Deborah T Blumenthal, Nancy Ann Oberheim Bush, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
International Journal of Computer Assisted Radiology and Surgery|December 23, 2017
MRI radiomics analysis of molecular alterations in low-grade gliomasBen Shofty, Moran Artzi, Dafna Ben Bashat, et al.
Journal of Neuro-Oncology|May 6, 2015
Calcification in high grade gliomas treated with bevacizumabDeborah T Blumenthal, Orna Aisenstein, Idan Ben-Horin, et al.
Neuro-Oncology|July 10, 2020
Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition geneLisa A Cannon-Albright, James M Farnham, Jeffrey Stevens, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 17, 2017
Regression of intracranial meningioma following treatment with nivolumab: Case report and review of the literatureEfrat Gelerstein, Assaf Berger, Tali Jonas-Kimchi, et al.
Journal of Neurosurgery|November 26, 2014
Conflicting pathology reports: a diagnostic dilemmaTal Shahar, Uri Rozovski, Yuval Shapira, et al.
American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.
Journal of Neuro-Oncology|January 5, 2008
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)Lode J Swinnen, Cathryn Rankin, Hetty Carraway, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Journal of Neuro-Oncology|June 15, 2020
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practiceWenyin Shi, Deborah T Blumenthal, Nancy Ann Oberheim Bush, et al.
Journal of Neuro-Oncology|January 5, 2021
Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practiceWenyin Shi, Deborah T Blumenthal, Nancy Ann Oberheim Bush, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
International Journal of Computer Assisted Radiology and Surgery|December 23, 2017
MRI radiomics analysis of molecular alterations in low-grade gliomasBen Shofty, Moran Artzi, Dafna Ben Bashat, et al.
Journal of Neuro-Oncology|May 6, 2015
Calcification in high grade gliomas treated with bevacizumabDeborah T Blumenthal, Orna Aisenstein, Idan Ben-Horin, et al.
Neuro-Oncology|July 10, 2020
Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition geneLisa A Cannon-Albright, James M Farnham, Jeffrey Stevens, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 17, 2017
Regression of intracranial meningioma following treatment with nivolumab: Case report and review of the literatureEfrat Gelerstein, Assaf Berger, Tali Jonas-Kimchi, et al.
Journal of Neurosurgery|November 26, 2014
Conflicting pathology reports: a diagnostic dilemmaTal Shahar, Uri Rozovski, Yuval Shapira, et al.
American Journal of Clinical Oncology|September 17, 2016
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397)Paul L Moots, Anne O'Neill, Harold Londer, et al.
Journal of Neuro-Oncology|January 5, 2008
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)Lode J Swinnen, Cathryn Rankin, Hetty Carraway, et al.
Pageof 23